We protect your health through science
Investigation
Serology
Publications
Bertuzzi M, Schrettl M, Alcazar-Fuoli L, Cairns TC, Muñoz A, Walker LA, Herbst S, Safari M, Cheverton AM, Chen D, Liu H, Saijo S, Fedorova ND, Armstrong-James D, Munro CA, Read ND, Filler SG, Espeso EA, Nierman WC, Haas H, Bignell EM. The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis. PLoS Pathog. 2014 Oct 16;10(10):e1004413. doi: 10.1371/journal.ppat.1004413.
Bertuzzi M, Schrettl M, Alcazar-Fuoli L, Cairns TC, Muñoz A, Walker LA, Herbst S, Safari M, Cheverton AM, Chen D, Liu H, Saijo S, Fedorova ND, Armstrong-James D, Munro CA, Read ND, Filler SG, Espeso EA, Nierman WC, Haas H, Bignell EM. The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis. PLoS Pathog. 2014 Oct 16;10(10):e1004413. doi: 10.1371/journal.ppat.1004413.
DOIYasmin S, Alcazar-Fuoli L, Gründlinger M, Puempel T, Cairns T, Blatzer M, Lopez JF, Grimalt JO, Bignell E, Haas H. Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):E497-504. doi: 10.1073/pnas.1106399108. Epub 2011 Nov 21. PMID: 22106303; PMCID: PMC3286978.
Yasmin S, Alcazar-Fuoli L, Gründlinger M, Puempel T, Cairns T, Blatzer M, Lopez JF, Grimalt JO, Bignell E, Haas H. Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):E497-504. doi: 10.1073/pnas.1106399108. Epub 2011 Nov 21. PMID: 22106303; PMCID: PMC3286978.
PUBMED DOIImpaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity. Vigón L, Fuertes D, García-Pérez J, Torres M, Rodríguez-Mora S, Mateos E, Corona M, Saez-Marín AJ, Malo R, Navarro C, Murciano-Antón MA, Cervero M, Alcamí J, García-Gutiérrez V, Planelles V, López-Huertas MR, Coiras M (AC). Front Immunol. 2021 May 26;12:665329. doi: 10.3389/fimmu.2021.665329. eCollection 2021. PMID: 34122423.
PUBMED DOIIdentification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission. Vigón L, Luna A, Galán M, Rodríguez-Mora S, Fuertes D, Mateos E, Piris-Villaespesa M, Bautista G, San José E, Rivera-Torres J, Steegmann JL, de Ory F, Pérez-Olmeda M, Alcamí J, Planelles V, López-Huertas MR, García-Gutiérrez V, Coiras M (AC). J Clin Med. 2020 Dec 25;10(1):42. doi: 10.3390/jcm10010042. PMID: 33375572.
PUBMED DOIAdditional Information
The main objective of the Serology Laboratory is to provide services to centers of the National Health System, through the offer in the service portfolio of the National Microbiology Center, in carrying out diagnosis and reference through the detection of antibodies, both for primary diagnosis and for reference activities.
For this, it has the appropriate serological methodologies, many of them accredited by ENAC in accordance with the ISO15189 standard. Conducts test validation studies through collaboration agreements with private entities.
Participates in seroprevalence studies, carried out through management assignments with the Ministry of Health and with the Public Health authorities of different autonomous communities.
On the other hand, it participates in research projects in relation to infectious diseases, in recent years on neurological diseases, on emerging diseases and on the viruses included in the MMR vaccine.
The main objective of the Serology Laboratory is to provide services to centers of the National Health System, through the offer in the service portfolio of the National Microbiology Center, in carrying out diagnosis and reference through the detection of antibodies, both for primary diagnosis and for reference activities.
For this, it has the appropriate serological methodologies, many of them accredited by ENAC in accordance with the ISO15189 standard. Conducts test validation studies through collaboration agreements with private entities.
Participates in seroprevalence studies, carried out through management assignments with the Ministry of Health and with the Public Health authorities of different autonomous communities.
On the other hand, it participates in research projects in relation to infectious diseases, in recent years on neurological diseases, on emerging diseases and on the viruses included in the MMR vaccine.